Both PLENITUDE and MULTI-STR3AM involve evaluating biorefinery-derived fractions (proteins, lipids, pigments, carotenoids) as candidate inputs for IFF product lines.
INTERNATIONAL FLAVORS & FRAGRANCES IFF (NEDERLAND) BV
Global flavor and fragrance manufacturer validating bio-based ingredient streams from mycoprotein and microalgae biorefineries.
Their core work
IFF is a global leader in taste, scent, and nutrition — they produce the flavor and fragrance compounds that go into food products, beverages, cosmetics, and household goods sold by major consumer brands worldwide. Their Netherlands R&D arm applies industrial fermentation, extraction, and bioprocessing expertise to develop natural ingredients at scale. In the H2020 program, they contributed as an industry end-user and formulation expert, testing whether proteins, pigments, carotenoids, and fragrance compounds derived from fungal or microalgae biorefinery processes meet the quality and cost standards required for commercial product lines. This positions them at the intersection of industrial biotechnology and consumer ingredients manufacturing.
What they specialise in
PLENITUDE specifically targets zero-waste mycoprotein biorefinery, where IFF's role as an industry partner implies expertise in assessing protein quality for food and ingredient applications.
MULTI-STR3AM explores multi-product microalgae biorefinery yielding omega-3, pigments, and fragrance fractions — precisely the value-added compounds IFF would formulate into end products.
Both projects emphasize zero-waste biorefinery and cascading valorisation of side streams, consistent with IFF's publicly stated sustainability commitments in raw material sourcing.
How they've shifted over time
IFF's H2020 engagement began in 2019 with PLENITUDE, which focused narrowly on fungal/mycoprotein biorefinery as a zero-waste protein source. By 2020 they joined MULTI-STR3AM, which broadened scope to microalgae and explicitly included fragrance fractions alongside food, feed, omega-3, and pigment streams — a direct link to their core business. The shift suggests they moved from exploring alternative proteins as a food ingredient trend to actively investing in bio-based fragrance and specialty lipid supply chains, aligning biorefinery research more tightly with their commercial product portfolio.
IFF is moving toward securing bio-based, sustainably sourced supply chains for fragrance, omega-3, and pigment ingredients — future collaboration opportunities likely lie in microalgae cultivation, natural fragrance extraction, and circular bioprocessing at industrial scale.
How they like to work
IFF participates exclusively as a consortium partner, never as coordinator — consistent with a large company that joins research consortia to validate emerging ingredients against industrial standards rather than to manage research programs. Their 25 partners across 9 countries across just 2 projects indicates they work in broad, international consortia typical of Innovation Actions. As a large multinational, they bring industrial end-user credibility and formulation know-how that strengthens the commercial viability case for any project proposal.
IFF has built a network of 25 consortium partners across 9 countries through only 2 projects, reflecting the large, multi-partner consortia typical of H2020 Innovation Actions in the biorefinery and food space. Their geographic footprint is pan-European with likely connections to agri-food, biotech, and academic partners across Western and Northern Europe.
What sets them apart
IFF is one of the very few companies in the H2020 database that bridges the fragrance/flavor industry with biorefinery and alternative protein research — most food-sector participants focus on one or the other. Their combination of global formulation expertise and direct interest in microalgae and fungal-derived ingredient streams makes them a uniquely credible end-user partner for any biorefinery project that needs a large industry offtaker to validate commercial relevance. Consortium builders seeking to demonstrate a clear route to market for bio-based specialty ingredients would find IFF's participation a strong signal to evaluators.
Highlights from their portfolio
- MULTI-STR3AMThe highest-funded of IFF's two projects (€330,923) and the one that most directly ties their fragrance business to biorefinery science, making it a rare public record of IFF investing in bio-based fragrance ingredient R&D.
- PLENITUDEA long-horizon project (2019–2025) targeting first-of-its-kind large-scale mycoprotein biorefinery, where IFF's involvement signals early-mover interest in fungal protein as a food ingredient before the market went mainstream.